𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma : Pooled analysis of 2805 patients

✍ Scribed by Emilio Bria; Diana Giannarelli; Alessandra Felici; William P. Peters; Cecilia Nisticò; Barbara Vanni; Federica Cuppone; Francesco Cognetti; Edmondo Terzoli

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
118 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of adjuvant chemotherapy on outco
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy
✍ Jean-Yves Pierga; Bernard Asselain; Michel Jouve; Véronique Diéras; Mathieu Cart 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## BACKGROUND. The objective of the current study was to analyze the impact of adjuvant chemotherapy in comparison with other prognostic parameters on the outcome of a series of patients with breast carcinoma at time of metastatic recurrence. ## METHODS. Data from 1430 patients accrued in 8 pro

A phase II study of paclitaxel plus carb
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma
✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi

Pharmacoeconomic profile of paclitaxel a
Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma : A lifetime cost-effectiveness analysis
✍ Andrea Messori; Michele Cecchi; Paola Becagli; Sabrina Trippoli 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

medullary recurrence in certain ethnic groups will be the field have read the article. I agree that there is no proof that all-trans retinoic acid (ATRA) therapy confirmed by further observation and analysis of recurrence in the large cooperative group studying APL. predisposes patients to the deve